NEW YORK (GenomeWeb News) - EraGen Biosciences said today that it has received Health Canada approval to market five quantitative PCR-based in vitro diagnostics in the Canadian market.
Health Canada approved the company’s tests for Bordetella pertussis and B. parapertussis; Enterovirus; influenza types A and B; herpes simplex virus 1 and 2; and cytomegalovirus.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.